The Technical Analyst
Select Language :
Harrow Health Inc [HROW]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Harrow Health Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Harrow Health Inc is listed at the  Exchange

3.93% $13.23

America/New_York / 28 mar 2024 @ 16:00


Harrow Health Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 467.85 mill
EPS: -0.750
P/E: -17.64
Earnings Date: May 08, 2024
SharesOutstanding: 35.36 mill
Avg Daily Volume: 0.446 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -17.64 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.37x
Company: PE -17.64 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 12.57 - 13.81

( +/- 4.71%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-28 Opaleye Management Inc. Buy 50 000 Common Stock, par value $0.001 per share
2024-03-22 Baum Mark L Buy 9 000 Common stock
2024-03-20 Opaleye Management Inc. Buy 50 600 Common Stock, par value $0.001 per share
2024-03-01 Saharek John P. Buy 5 000 Common stock
2024-03-01 Saharek John P. Sell 5 000 Stock Option (Right to Buy)
INSIDER POWER
12.44
Last 96 transactions
Buy: 5 373 190 | Sell: 3 289 598

Forecast: 16:00 - $13.21

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $13.21
Forecast 2: 16:00 - $13.21
Forecast 3: 16:00 - $13.21
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $13.23 (3.93% )
Volume 0.830 mill
Avg. Vol. 0.446 mill
% of Avg. Vol 186.26 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Harrow Health Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Harrow Health Inc

RSI

Intraday RSI14 chart for Harrow Health Inc

Last 10 Buy & Sell Signals For HROW

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$10.28N/AActive
Profile picture for
            Harrow Health Inc

HROW

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59
IONUSDMar 29 - 04:08452.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.